Monoclonal antibody fragment treatments for 'wet' macular degeneration keep elderly drivers behind the wheel, study suggests
Tuesday, October 2, 2012 - 17:12
in Mathematics & Economics
The advanced neovascular, or "wet," form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But results of a new study suggest that monthly injections of ranibizumab improve eye chart test results required for a driver's license, build driver confidence and keep those with AMD driving longer.